Evidence map›Paper›PMID 35518701›Full record

ArticleRSC advances2019

Fully automated peptide radiolabeling from [

Ryan A Davis, Chris Drake, Robin C Ippisch, Melissa Moore, Julie L Sutcliffe

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Rapid cleavage of 6-[EJNMMI radiopharmacy and chemistry · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. A Fully Automated Synthesis of 14-(Pharmaceuticals (Basel, Switzerland) · 2024
    Article
  7. Automated light-induced synthesis ofScientific reports · 2022
    Article
  8. Article
  9. Article
  10. Journal of the American Chemical Society · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ryan A DavisDepartment of Internal Medicine, Division of Hematology and Oncology, University of California Davis CA USA jlsutcliffe@ucdavis.edu +1-916-734-7572 +1-916-734-5536.ORCID https://orcid.org/0000-0002-0638-870X
Chris DrakeSofie Co. Culver City CA USA.
Robin C IppischDepartment of Biomedical Engineering, University of California Davis CA USA.
Melissa MooreSofie Co. Culver City CA USA.
Julie L SutcliffeDepartment of Internal Medicine, Division of Hematology and Oncology, University of California Davis CA USA jlsutcliffe@ucdavis.edu +1-916-734-7572 +1-916-734-5536.ORCID https://orcid.org/0000-0002-5485-4082
University of California System · USSofie Biosciences (United States) · US

Funding

Commercialization of a Benchtop Radiosynthesizer for the Production of PET ProbesR44MH097271 · NIMH · SOFIE BIOSCIENCES, INC. · PI MOORE, MELISSA · 2013 to 2018
$3.8M
Fully automated enzymatic radiolabeling of biomoleculesR43EB023782 · NIBIB · SOFIE BIOSCIENCES, INC. · PI MOORE, MELISSA · 2016 to 2016
$179k
NCI NIH HHS HHSN261201400041CNIBIB NIH HHS R43 EB023782NIMH NIH HHS R44 MH097271
6 · The paper itself

Abstract

The biological properties of receptor-targeted peptides have made them popular diagnostic imaging and therapeutic agents. Typically, the synthesis of fluorine-18 radiolabeled receptor-targeted peptides for positron emission tomography (PET) imaging is a time consuming, complex, multi-step synthetic process that is highly variable based on the peptide. The complexity associated with the radiolabeling route and lack of robust automated protocols can hinder translation into the clinic. A fully automated batch production to radiolabel three peptides (YGGFL, cRGDyK, and Pyr-QKLGNQWAVGHLM) from fluorine-18 using the ELIXYS FLEX/CHEM® radiosynthesizer in a two-step process is described. First, the prosthetic group, 6-[

Identifiers

PMID35518701
PMCPMC9061836
OpenAlexW2922255023

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.